Searched for
SINGULAIR
Unichem Labs gets USFDA nod for asthma drugThe tablets are indicated for prophylaxis and chronic treatment of asthma in adults and pediatric patients - 12 months of age and older.- Ajanta Pharma launches generic asthma treatment tablets in USAjanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American marke...
- Sensex gains over 100 points, Nifty tests 7,850; Shree Renuka Sugars gains 7%, Eros 2%The S&P BSE Sensex rallied over 100 points tracking the gains seen in other Asian markets.
- Ten stocks in focus in Tuesday morning tradeThe Indian market is expected to trade higher. Here is a list of top ten stocks that are likely to be in focus today.
- Ajanta Pharma launches generic asthma drug in US marketAjanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market.
- Unichem gets USFDA nod for generic asthma treatment tabletsDrug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and...
- Jubilant Life gets USFDA nod for generic anti-asthma tablets"This includes 72 ANDAs filed in the US, of which 35 have been approved and 46 dossier filings in Europe. So far, we have received 10 ANDA ...
- Glenmark Generics recalls anti-asthma drug from US marketGlenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg) on "off-odour" complaints.
- Dr Reddy's Laboratories launches generic anti-asthma drug in US marketDr Reddy's Laboratories has launched its generic Montelukast Sodium oral granules used for treating asthma and seasonal allergies in the US...
- Aurobindo Pharma, Glenmark get FDA nod for generic montelukast sodium tabletsNew Delhi Drug firms Aurobindo Pharma and Glenmark have received approval from the US health regulator to manufacture and market generic mo...
- Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drugAurobindo, Glenmark today said they have received approval from the US health regulator to manufacture, market generic montelukast tablets.
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drugIndian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...
- Indian drug outlook favourable: ICRA & Moody'sAccording to the report, domestic formulation market size stood at Rs 58,300 crore, ranked third in terms of volume and tenth in terms of v...
- Glenmark Pharmaceuticals receives USFDA tentative nod for anti-asthma tabletsGlenmark said it has received tentative approval from the US health regulator to market its tablets used for treating asthma and seasonal a...
- Merck Q1 sales rise but profit fall on chargesDrugmaker Merck & Co. says double-digit sales growth for a half-dozen of its top medicines fueled a 7 percent jump in first-quarter sales.
- Indian pharma players to benefit from generic drugs in USIncreased use of generic drugs helped the US healthcare system save billions of dollars over last decade. 6 mysteries about swine flu | Swi...
- Pfizer’s Wyeth bid may trigger rush for M&AsPfizer’s potential purchase of Wyeth for more than $60 billion may set off a rush to consolidate in an industry buffeted by a thinner pipel...
- FDA rejects Schering drug to reverse anesthesiaGovernment regulators dealt a major setback to Schering-Plough Corp, rejecting a highly anticipated drug designed to help patients recover ...
- Vioxx lawsuits pile up in US courtsA Surge of lawsuits has swamped courthouses just ahead of the two-year anniversary of drugmaker Merck pulling its blockbuster painkiller Vi...
Load More
